Refine by
Covid 19 Articles & Analysis
356 articles found
Vaccine Development: Adenoviral vectors are exploring new vaccination strategies, notably in the development of vaccines against infectious diseases, including COVID-19. Cancer Treatment: By delivering genes that can induce cancer cell death or enhance the immune response against tumors, adenoviruses are part of innovative approaches in oncology. ...
As we step into 2024, the global health landscape is increasingly focused on combatting viral infections, which continue to pose significant threats to public health. The COVID-19 pandemic has illuminated the critical need for innovative strategies in antiviral research, and scientists worldwide are embarking on groundbreaking projects to develop more effective ...
They are particularly important in the fight against rapidly mutating viruses, such as influenza and COVID-19. Diagnostic Tools In diagnostics, synthetic peptides serve as antigens in immunoassays and biosensors, helping to detect the presence of antibodies or pathogens in biological samples with high specificity and sensitivity. ...
Well, mRNA has become a crucial player, particularly in modern medicine. The COVID-19 pandemic opened the floodgates for mRNA research and applications, showing the world how critical mRNA technology can be. ...
Precision-Cut Lung Slices (PCLS) have emerged as a innovative ex vivo model that allows researchers to explore deep into lung physiology, disease mechanisms, and pharmacological responses. By offering a unique combination of biological complexity and controlled experimental conditions, PCLS serve as a critical bridge between the limitations of traditional in vitro cell cultures and the ...
Other test methods can include: · Endoscopic biopsies (invasive & costly) · Blood test (repeated every 30 minutes) · Stool acidity test (infants, young children) Home breath testing devices Home breath testing devices were more widely optimised due to the COVID-19 pandemic, to prevent waiting list delays and people ...
This has proven crucial in combating emerging infectious diseases like COVID-19, where traditional vaccine production methods have proven to be less agile in keeping up with rapidly evolving pathogens. ...
Welcome to 2023-2024 season’s respiratory surveillance recap, where we’ll share insights from the most recent respiratory surveillance season, covering three major respiratory viruses: COVID-19, influenza, and RSV. Tracking these illnesses is imperative for maintaining population health because these illnesses significantly impact individual wellbeing ...
In recent years, mRNA vaccines have emerged as a revolutionary tool in the fight against infectious diseases, including the ongoing COVID-19 pandemic. These vaccines utilize messenger RNA (mRNA) to instruct cells to produce a protein that triggers an immune response, leading to the production of antibodies that protect against the targeted virus. ...
We started by making this important data available during the COVID-19 pandemic to fill critical data gaps nationally in an easily digestible way. ...
Introduction RNA Lipid Nanoparticles (LNP) technology has rapidly gained prominence in the health and scientific domain, primarily due to its significant role in carrying the mRNA of the COVID-19 vaccines developed by Pfizer/BioNTech and Moderna. Yet, the potential of this technology spans beyond the confines of these vaccines or even the health industry. ...
Peru has been one of the hardest hit countries by the COVID-19 pandemic. The high death tolls and economical impacts will stunt the on-going development of so many underserved communities. ...
The COVID-19 pandemic has killed millions of people. Vaccines certainly are the most outstanding ways to prevent major diseases and death, though they haven't eliminated infections. ...
Combined adjuvants of CpG ODNs plus AH have been applied to different antigens, including COVID-19 RBD subunits and hepatitis b surface antigen (HbsAg), and the results demonstrated that the aluminum-adjuvanted vaccine combined with CpG induced a stronger and more balanced immune response of Th1/Th2 cells and a higher antibody response. ...
Over the past decade, cloud computing has undergone remarkable expansion. The collective revenue generated by AWS, Google Cloud, and Microsoft surged from $49 billion in 2018 to an astonishing $206 billion in 2022.[i] Projections from Future Market Insights indicate that the revenue from cloud services is poised to maintain an impressive average annual growth rate of 21%, reaching a staggering ...
During the COVID-19 pandemic, the success of mRNA vaccines has greatly propelled the development of mRNA therapeutics. mRNA is a negatively charged nucleic acid that serves as a template for protein synthesis in ribosomes. ...
The following article is a repost of an interview that originally appeared in OR Today “Spotlight On: John W. Cromwell, MD” with Caresyntax customer, John Cromwell, MD, FACS, associate chief medical officer and director of surgical quality and safety at University of Iowa Hospitals and Clinics. ...
From a vaccine perspective, the V3 loop of the gp120 envelope protein of HIV-1 (HIV envelope variable region 3, V3) has been identified as a candidate for peptide-based vaccine design as it is a target for neutralizing antibodies.SARS-CoV-2 and Related CoronavirusesThe global COVID-19 pandemic caused by the SARS-CoV-2 virus has spurred the rapid development of ...
Future of Cold Chain Systems The global health landscape has been forever altered by the COVID-19 pandemic. This unprecedented crisis underscored the critical importance of robust, efficient, and resilient cold chain systems, and the round table discussion delved into the significant investments made around the world in medical infrastructure in response to the ...
The recent COVID-19 pandemic again highlighted the urgent need for broad-spectrum antivirals, both for therapeutic use in acute viral infection and for pandemic preparedness in general. ...